Annual Interest Expense
$8.57 M
-$1.65 M-16.14%
December 31, 2022
Summary
- As of February 24, 2025, SRNE annual interest expense is $8.57 million, with the most recent change of -$1.65 million (-16.14%) on December 31, 2022.
- During the last 3 years, SRNE annual interest expense has fallen by -$26.47 million (-75.54%).
- SRNE annual interest expense is now -85.12% below its all-time high of $57.63 million, reached on December 31, 2018.
Performance
SRNE Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$2.67 M
+$1.54 M+135.69%
June 30, 2023
Summary
- As of February 24, 2025, SRNE quarterly interest expense is $2.67 million, with the most recent change of +$1.54 million (+135.69%) on June 30, 2023.
- Over the past year, SRNE quarterly interest expense has increased by +$1.54 million (+135.69%).
- SRNE quarterly interest expense is now -94.07% below its all-time high of $45.01 million, reached on June 30, 2018.
Performance
SRNE Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$6.81 M
+$354.00 K+5.48%
June 30, 2023
Summary
- As of February 24, 2025, SRNE TTM interest expense is $6.81 million, with the most recent change of +$354.00 thousand (+5.48%) on June 30, 2023.
- Over the past year, SRNE TTM interest expense has increased by +$354.00 thousand (+5.48%).
- SRNE TTM interest expense is now -89.63% below its all-time high of $65.66 million, reached on March 31, 2019.
Performance
SRNE TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
SRNE Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.1% | +135.7% | +5.5% |
| 3 y3 years | -75.5% | +135.7% | +5.5% |
| 5 y5 years | +72.2% | +135.7% | +5.5% |
SRNE Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | at low | -17.9% | +236.9% | -40.3% | +5.5% |
| 5 y | 5-year | -75.5% | at low | -67.8% | +236.9% | -80.6% | +5.5% |
| alltime | all time | -85.1% | -100.0% | -94.1% | -100.0% | -89.6% | -100.0% |
Sorrento Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $2.67 M(+135.7%) | $6.81 M(+5.5%) |
| Mar 2023 | - | $1.13 M(-49.0%) | $6.46 M(-24.7%) |
| Dec 2022 | $8.57 M(-16.1%) | $2.22 M(+180.2%) | $8.57 M(-7.8%) |
| Sep 2022 | - | $792.00 K(-65.8%) | $9.30 M(-18.5%) |
| Jun 2022 | - | $2.31 M(-28.8%) | $11.40 M(+2.7%) |
| Mar 2022 | - | $3.25 M(+10.4%) | $11.11 M(+8.6%) |
| Dec 2021 | $10.22 M(-49.3%) | $2.94 M(+1.4%) | $10.22 M(+4.6%) |
| Sep 2021 | - | $2.90 M(+43.8%) | $9.78 M(+3.6%) |
| Jun 2021 | - | $2.02 M(-14.8%) | $9.44 M(-40.0%) |
| Mar 2021 | - | $2.37 M(-5.1%) | $15.72 M(-22.0%) |
| Dec 2020 | $20.16 M(-42.5%) | $2.49 M(-2.7%) | $20.16 M(-18.2%) |
| Sep 2020 | - | $2.56 M(-69.1%) | $24.65 M(-21.9%) |
| Jun 2020 | - | $8.29 M(+21.9%) | $31.55 M(-3.7%) |
| Mar 2020 | - | $6.81 M(-2.6%) | $32.77 M(-6.5%) |
| Dec 2019 | $35.05 M(-39.2%) | $6.99 M(-26.1%) | $35.05 M(-5.1%) |
| Sep 2019 | - | $9.46 M(-0.6%) | $36.95 M(+22.5%) |
| Jun 2019 | - | $9.52 M(+4.8%) | $30.17 M(-54.0%) |
| Mar 2019 | - | $9.08 M(+2.2%) | $65.66 M(+13.9%) |
| Dec 2018 | $57.63 M(+1057.2%) | $8.89 M(+231.1%) | $57.63 M(+15.9%) |
| Sep 2018 | - | $2.68 M(-94.0%) | $49.71 M(+2.5%) |
| Jun 2018 | - | $45.01 M(+4178.4%) | $48.50 M(+934.5%) |
| Mar 2018 | - | $1.05 M(+9.2%) | $4.69 M(-10.6%) |
| Dec 2017 | $4.98 M | $963.00 K(-34.6%) | $5.25 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $1.47 M(+22.8%) | $5.16 M(+32.4%) |
| Jun 2017 | - | $1.20 M(-25.4%) | $3.90 M(+31.2%) |
| Mar 2017 | - | $1.61 M(+83.3%) | $2.97 M(+78.1%) |
| Dec 2016 | $1.61 M(-2.5%) | $878.00 K(+318.1%) | $1.67 M(+43.2%) |
| Sep 2016 | - | $210.00 K(-23.1%) | $1.17 M(-13.8%) |
| Jun 2016 | - | $273.00 K(-11.1%) | $1.35 M(-11.1%) |
| Mar 2016 | - | $307.00 K(-18.1%) | $1.52 M(-8.0%) |
| Dec 2015 | $1.65 M(+1.4%) | $375.00 K(-5.3%) | $1.65 M(-5.0%) |
| Sep 2015 | - | $396.00 K(-10.4%) | $1.74 M(-4.4%) |
| Jun 2015 | - | $442.00 K(+0.7%) | $1.82 M(-1.4%) |
| Mar 2015 | - | $439.00 K(-5.0%) | $1.84 M(+13.3%) |
| Dec 2014 | $1.63 M(+543.9%) | $462.00 K(-2.9%) | $1.63 M(+21.8%) |
| Sep 2014 | - | $476.00 K(+1.7%) | $1.34 M(+46.6%) |
| Jun 2014 | - | $468.00 K(+109.9%) | $912.00 K(+95.7%) |
| Mar 2014 | - | $223.00 K(+31.2%) | $466.00 K(+84.2%) |
| Dec 2013 | $253.00 K(>+9900.0%) | $170.00 K(+233.3%) | $253.00 K(+204.8%) |
| Sep 2013 | - | $51.00 K(+131.8%) | $83.00 K(+159.4%) |
| Jun 2013 | - | $22.00 K(+120.0%) | $32.00 K(+220.0%) |
| Mar 2013 | - | $10.00 K(>+9900.0%) | $10.00 K(>+9900.0%) |
| Dec 2012 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
FAQ
- What is Sorrento Therapeutics annual interest expense?
- What is the all time high annual interest expense for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual interest expense year-on-year change?
- What is Sorrento Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly interest expense year-on-year change?
- What is Sorrento Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Sorrento Therapeutics?
- What is Sorrento Therapeutics TTM interest expense year-on-year change?
What is Sorrento Therapeutics annual interest expense?
The current annual interest expense of SRNE is $8.57 M
What is the all time high annual interest expense for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual interest expense is $57.63 M
What is Sorrento Therapeutics annual interest expense year-on-year change?
Over the past year, SRNE annual interest expense has changed by -$1.65 M (-16.14%)
What is Sorrento Therapeutics quarterly interest expense?
The current quarterly interest expense of SRNE is $2.67 M
What is the all time high quarterly interest expense for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly interest expense is $45.01 M
What is Sorrento Therapeutics quarterly interest expense year-on-year change?
Over the past year, SRNE quarterly interest expense has changed by +$1.54 M (+135.69%)
What is Sorrento Therapeutics TTM interest expense?
The current TTM interest expense of SRNE is $6.81 M
What is the all time high TTM interest expense for Sorrento Therapeutics?
Sorrento Therapeutics all-time high TTM interest expense is $65.66 M
What is Sorrento Therapeutics TTM interest expense year-on-year change?
Over the past year, SRNE TTM interest expense has changed by +$354.00 K (+5.48%)